despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6.
.anjali shrivastava covers academics and administration. contact her at
.
when his patients ask how long they’ll be at the hospital with a procedure like this, he tries to manage their expectations.
.
.
.